Attached files

file filename
EX-32.2 - CERTIFICATION - Advanced Biomedical Technologies Inc.abmt_ex322.htm
EX-32.1 - CERTIFICATION - Advanced Biomedical Technologies Inc.abmt_ex321.htm
EX-31.2 - CERTIFICATION - Advanced Biomedical Technologies Inc.abmt_ex312.htm
EX-31.1 - CERTIFICATION - Advanced Biomedical Technologies Inc.abmt_ex311.htm
10-Q - QUARTERLY REPORT - Advanced Biomedical Technologies Inc.abmt_10q.htm
v3.2.0.727
Label Element Value
NET LOSS ATTRIBUTABLE TO ABMT COMMON STOCKHOLDERS us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic $ (184,764)
NET LOSS ATTRIBUTABLE TO ABMT COMMON STOCKHOLDERS us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic (217,662)
Depreciation us-gaap_Depreciation 6,662
Depreciation us-gaap_Depreciation $ 7,914